RPL36AP51

Across TCGA pan-cancer cohorts, RPL36AP51 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPL36AP51’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RPL36AP51 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL36AP51 is over-expressed in tumor.

LUAD, KIRC, and HNSC are the cancer types where RPL36AP51 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL36AP51 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.121	.002	5	view →
KIRC	Female	All	+0.082	.006	5	view →
HNSC	All	All	+0.111	.005	4	view →
COAD	All	II,III,IV	+0.142	.033	2	view →
LIHC	All	All	+0.035	.031	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RPL36AP51–LUAD

Open the LUAD breakdown →